The goal of Biogen Digital Health is to advance the application of health technologies and digital medicine. Our goal is to grow our commercial influence, derisk and speed up our R&D engine, and advance human health.
Biogen collaborates with evidence-based digital health innovators from all around the ecosystem who are committed to discovering cutting-edge solutions that have the potential to revolutionize patient care. As the field evolves and becomes more closely aligned with Biogen's future priorities and areas of concentration, we think it is important to take advantage of external talents and relationships.
Clinically validated AI-based assistive software for the detection and quantification of ARIA, which could improve safety monitoring and management of Alzheimer’s disease patients treated with amyloid beta-directed monoclonal antibodies.
Proprietary patient-centric digital biomarker platform to assess neurological functions remotely for more precise, frequent measurement of disease evolution, for example for Parkinson’s.
Digital exercise platform that offers at-home, tailored programs for people living with neuromuscular diseases.
Virtual reality (VR) solution to improve neuromuscular disease patients’ experience during medical procedures